Moderators : Kenneth Rosenfield, MD, MSCAI and Victor Tapson, MD
• Introduction, Kenneth Rosenfield, MD, MSCAI
• Acute PE Disease, Victor Tapson, MD
• Risk Stratification and Options for Treatment in Intermediate-Risk PE, Gregory Piazza, MD, MS
• Management Decisions and Role of PERT, Kenneth Rosenfield, MD, MSCAI
• Case Discussion
• HI-PEITHO: A Landmark Randomized Trial: Design and Goals, Stavros Konstantinides, MD, PhD, FESC
• Panel Discussion, Q&A
Learning Objectives
After completing this activity, participants should be able to:
- Describe the symptoms of acute pulmonary embolism (PE) disease.
- Discuss risk stratification and options for treatment in intermediate-risk PE.
- Summarize the role of the pulmonary embolism response team (PERT).
- Analyze the designs and goals of the HI-PEITHO randomized trial.
Acknowledgment of Commercial Support
This activity was supported by an unrestricted educational grant from Boston Scientific. No in-kind commercial support was received.
Continuing Education Information
Accreditation Statement
The Society for Cardiovascular Angiography and Interventions (SCAI) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
ABIM MOC
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1 medical knowledge MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
Successful Completion
Watch the content and complete the evaluation to obtain credit.